# Intermittent Versus Continuous Tarceva Study

> **NCT01243047** · PHASE2 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 60 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT01243047
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2012-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01243047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01243047, "Intermittent Versus Continuous Tarceva Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01243047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*